2026 Blue Shield Rx Enhanced (PDP) formulary (drug list)
Contract S2468, plan 004 · California · 3,198 drugs on file · formulary ID 00026294. Each drug links to its cost in every CMS PDP Region 32 plan.
5 drugs starting with Y.
| Drug name | Tier | 30-day preferred pharmacy | 90-day mail order | Usage management |
|---|---|---|---|---|
| YESINTEK 45 mg/.5mL Injection, SolutionUstekinumab | 4Non-Preferred Drug | 37% | 37% |
|
| YESINTEK 45 mg/.5mL Injection, SolutionUstekinumab | 4Non-Preferred Drug | 37% | 37% |
|
| YESINTEK 90 mg/mL Injection, SolutionUstekinumab | 5Specialty Tier | 33% | N/A |
|
| YF-VAX 4.74 [PFU]/.5mL Injection, Powder, Lyophilized, For SuspensionYellow Fever Virus Strain 17D-204 Live Antigen | 4Non-Preferred Drug | 37% | 37% | None |
| YUVAFEM 10 ug TabletEstradiol | 3Preferred Brand | 19% | 19% | None |
PA = prior authorization, ST = step therapy, QL = quantity limit. Costs are the plan’s initial-coverage cost-sharing from the CMS 2026 formulary files; a drug not listed here is not on this plan’s formulary, though a formulary exception may still be possible.